Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
International Journal of Molecular Sciences|October 12, 2018
Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase InhibitorsJohanna S UngerstedtJournal of Neurosurgical Anesthesiology|December 25, 2002
Clotting onset time may be a predictor of outcome in human brain injury: a pilot studyJohanna S Ungerstedt, Asa Grenander, Sixten Bredbacka, et al.Thrombosis Research|December 31, 2003
Bedside monitoring of coagulation activation after challenging healthy volunteers with intravenous endotoxinJohanna S Ungerstedt, Anne Soop, Alf Sollevi, et al.Blood Advances|September 13, 2018
Deciphering the differentiation trajectory from hematopoietic stem cells to mast cellsJennine Grootens, Johanna S Ungerstedt, Gunnar Nilsson, et al.The Journal of Biological Chemistry|February 17, 2006
Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductaseSeyed Isaac Hashemy, Johanna S Ungerstedt, Farnaz Zahedi Avval, et al.Acta Diabetologica|July 10, 2013
Plasma glutaredoxin activity in healthy subjects and patients with abnormal glucose levels or overt type 2 diabetesYatao Du, Huihui Zhang, Sergio Montano, et al.Nephron|September 26, 2018
Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot StudyAnna Levin, Deepika Nair, Abdul Rashid Qureshi, et al.BBA Clinical|March 12, 2016
Glutaredoxin mediated redox effects of coenzyme Q10 treatment in type 1 and type 2 diabetes patientsSergio J Montano, Jacob Grünler, Deepika Nair, et al.Blood|August 10, 2017
KIT signaling is dispensable for human mast cell progenitor developmentJoakim S Dahlin, Maria Ekoff, Jennine Grootens, et al.Ebiomedicine|April 13, 2019
Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosisJennine Grootens, Johanna S Ungerstedt, Maria Ekoff, et al.Pageof 2